Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.500
+0.005 (0.33%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $6.25 million as of August 14, 2026. Its market cap has decreased by -5.64% in one year.
Market Cap
6.25M
Enterprise Value
229.54K
1-Year Change
-5.64%
Ranking
Category
Stock Price
$1.50
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $6.25M, an increase of 25.79%. That is a compound annual growth rate of 1.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.25M | -10.62% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imunon | 6.64M |
| Liminatus Pharma | 6.61M |
| XTL Biopharmaceuticals | 6.59M |
| Evogene | 6.48M |
| Curanex Pharmaceuticals | 6.41M |
| Bolt Biotherapeutics | 6.25M |
| Cardio Diagnostics Holdings | 6.10M |
| NuCana | 6.08M |